Safe Orthopaedics SA (ALSAF.PA)
0.0212 €
+0.00 (+2.91%)
Rating:
Recommendation:
-
| Symbol | ALSAF.PA |
|---|---|
| Price | 0.0212 € |
| Beta | 2.208 |
| Volume Avg. | 0.80M |
| Market Cap | 1.317M |
| Shares () | - |
| 52 Week Range | 0.0202-0.559 |
| 1y Target Est | - |
| DCF Unlevered | ALSAF.PA DCF -> | |
|---|---|---|
| DCF Levered | ALSAF.PA LDCF -> | |
| ROE | 10963.10% | Strong Buy |
| ROA | -49.92% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 3657.07% | Strong Buy |
| P/E | - | |
| P/B | 0.03 | Neutral |
About
Download (Excel)Mr. Pierre Dumouchel
Healthcare
Medical Instruments & Supplies
Paris
Safe Orthopaedics SA, a medical technology company, develops and markets sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company offers SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies; and SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems. It also provides SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was founded in 2010 and is headquartered in Éragny-sur-Oise, France.